2DWG - Header Asymmetric Unit

HEADER PROTEIN BINDING 11-AUG-06 2DWG

TITLE RUN DOMAIN OF RAP2 INTERACTING PROTEIN X, CRYSTALLIZED IN TITLE 2 P2(1)2(1)2(1) SPACE GROUP

COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN RUFY3; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RUN DOMAIN; COMPND 5 SYNONYM: RAP2-INTERACTING PROTEIN X, RIPX; COMPND 6 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: RUFY3, D5BWG0860E, RIPX; SOURCE 6 EXPRESSION_SYSTEM: CELL FREE SYNTHESIS; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PK011025-09; SOURCE 9 OTHER_DETAILS: CELL FREE PROTEIN SYNTHESIS

KEYWDS RUN DOMAIN, EFFECTOR, RAP2, BUNDLE, PROTEIN BINDING, KEYWDS 2 STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN KEYWDS 3 STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL KEYWDS 4 GENOMICS/PROTEOMICS INITIATIVE, RSGI

EXPDTA X-RAY DIFFRACTION

AUTHOR M.KUKIMOTO-NIINO,K.MURAYAMA,M.SHIROUZU,S.YOKOYAMA,RIKEN AUTHOR 2 STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE (RSGI)

REVDAT 2 24-FEB-09 2DWG 1 VERSN REVDAT 1 24-OCT-06 2DWG 0

JRNL AUTH M.KUKIMOTO-NIINO,T.TAKAGI,R.AKASAKA,K.MURAYAMA, JRNL AUTH 2 T.UCHIKUBO-KAMO,T.TERADA,M.INOUE,S.WATANABE, JRNL AUTH 3 A.TANAKA,Y.HAYASHIZAKI,T.KIGAWA,M.SHIROUZU, JRNL AUTH 4 S.YOKOYAMA JRNL TITL CRYSTAL STRUCTURE OF THE RUN DOMAIN OF THE JRNL TITL 2 RAP2-INTERACTING PROTEIN X JRNL REF J.BIOL.CHEM. V. 281 31843 2006 JRNL REFN ISSN 0021-9258 JRNL PMID 16928684 JRNL DOI 10.1074/JBC.M604960200

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. 3.22 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.22 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.02 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1392154.690 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 6798 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.292 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.900 REMARK 3 FREE R VALUE TEST SET COUNT : 743 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.011 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.40 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 88.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 897 REMARK 3 BIN R VALUE (WORKING SET) : 0.2900 REMARK 3 BIN FREE R VALUE : 0.3820 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 100 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.038 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2460 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 31 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 29.56000 REMARK 3 B22 (A**2) : -8.39000 REMARK 3 B33 (A**2) : -21.18000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.54 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.52 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.65 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.00 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.61 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 14.01 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 2DWG COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 18-AUG-06. REMARK 100 THE RCSB ID CODE IS RCSB025927.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-OCT-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL26B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6828 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 6.492 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.14400 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.6818 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.31 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.31000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.922 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1WUS REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.4M LITHIUM SULFATE, 0.1M HEPES- REMARK 280 NA, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 300K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.81250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.27700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.83700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.27700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.81250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.83700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 76 REMARK 465 SER A 77 REMARK 465 SER A 78 REMARK 465 GLY A 79 REMARK 465 SER A 80 REMARK 465 SER A 81 REMARK 465 GLY A 82 REMARK 465 LYS A 137 REMARK 465 LYS A 138 REMARK 465 THR A 139 REMARK 465 PHE A 140 REMARK 465 LEU A 141 REMARK 465 GLY A 142 REMARK 465 GLN A 143 REMARK 465 ASP A 248 REMARK 465 SER A 249 REMARK 465 GLN A 250 REMARK 465 VAL A 251 REMARK 465 GLY A 252 REMARK 465 VAL A 253 REMARK 465 ILE A 254 REMARK 465 ASP A 255 REMARK 465 GLY B 76 REMARK 465 SER B 77 REMARK 465 SER B 78 REMARK 465 GLY B 79 REMARK 465 SER B 80 REMARK 465 SER B 81 REMARK 465 GLY B 82 REMARK 465 LYS B 137 REMARK 465 LYS B 138 REMARK 465 THR B 139 REMARK 465 PHE B 140 REMARK 465 LEU B 141 REMARK 465 GLY B 142 REMARK 465 GLN B 143 REMARK 465 ASP B 248 REMARK 465 SER B 249 REMARK 465 GLN B 250 REMARK 465 VAL B 251 REMARK 465 GLY B 252 REMARK 465 VAL B 253 REMARK 465 ILE B 254 REMARK 465 ASP B 255

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 108 -72.16 -55.79 REMARK 500 SER A 146 -155.20 70.15 REMARK 500 PHE A 147 8.39 -64.77 REMARK 500 PRO A 159 -14.82 -48.67 REMARK 500 GLU A 220 -169.84 -106.41 REMARK 500 LEU A 230 0.85 -59.56 REMARK 500 ASN A 239 105.02 -163.02 REMARK 500 PHE A 240 53.14 -108.00 REMARK 500 LYS A 243 -29.76 174.51 REMARK 500 GLU A 245 -89.61 23.87 REMARK 500 ASP A 246 -10.53 77.09 REMARK 500 ASP B 113 -164.33 -126.89 REMARK 500 TYR B 116 109.09 -51.94 REMARK 500 SER B 146 -142.41 56.50 REMARK 500 ASP B 170 19.38 52.51 REMARK 500 LYS B 204 51.04 -148.19 REMARK 500 PHE B 240 58.52 -105.52 REMARK 500 CYS B 241 17.86 -140.38 REMARK 500 LYS B 243 -3.30 152.22 REMARK 500 GLU B 245 -66.57 49.07 REMARK 500 ASP B 246 -12.07 64.48 REMARK 500 REMARK 500 REMARK: NULL

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1WUS RELATED DB: PDB REMARK 900 THE SAME PROTEIN CRYSTALLIZED IN P6(4)22 SPACE GROUP REMARK 900 RELATED ID: 2CXF RELATED DB: PDB REMARK 900 THE SAME PROTEIN CRYSTALLIZED IN C2 SPACE GROUP REMARK 900 RELATED ID: 2CXL RELATED DB: PDB REMARK 900 THE SAME PROTEIN CRYSTALLIZED IN I422 SPACE GROUP REMARK 900 RELATED ID: MMK001003772.6 RELATED DB: TARGETDB

DBREF 2DWG A 83 255 UNP Q9D394 RUFY3_MOUSE 65 237 DBREF 2DWG B 83 255 UNP Q9D394 RUFY3_MOUSE 65 237

SEQADV 2DWG GLY A 76 UNP Q9D394 CLONING ARTIFACT SEQADV 2DWG SER A 77 UNP Q9D394 CLONING ARTIFACT SEQADV 2DWG SER A 78 UNP Q9D394 CLONING ARTIFACT SEQADV 2DWG GLY A 79 UNP Q9D394 CLONING ARTIFACT SEQADV 2DWG SER A 80 UNP Q9D394 CLONING ARTIFACT SEQADV 2DWG SER A 81 UNP Q9D394 CLONING ARTIFACT SEQADV 2DWG GLY A 82 UNP Q9D394 CLONING ARTIFACT SEQADV 2DWG GLY B 76 UNP Q9D394 CLONING ARTIFACT SEQADV 2DWG SER B 77 UNP Q9D394 CLONING ARTIFACT SEQADV 2DWG SER B 78 UNP Q9D394 CLONING ARTIFACT SEQADV 2DWG GLY B 79 UNP Q9D394 CLONING ARTIFACT SEQADV 2DWG SER B 80 UNP Q9D394 CLONING ARTIFACT SEQADV 2DWG SER B 81 UNP Q9D394 CLONING ARTIFACT SEQADV 2DWG GLY B 82 UNP Q9D394 CLONING ARTIFACT

SEQRES 1 A 180 GLY SER SER GLY SER SER GLY MET ALA ASN GLU ARG MET SEQRES 2 A 180 ASN LEU MET ASN MET ALA LYS LEU SER ILE LYS GLY LEU SEQRES 3 A 180 ILE GLU SER ALA LEU ASN LEU GLY ARG THR LEU ASP SER SEQRES 4 A 180 ASP TYR ALA PRO LEU GLN GLN PHE PHE VAL VAL MET GLU SEQRES 5 A 180 HIS CYS LEU LYS HIS GLY LEU LYS ALA LYS LYS THR PHE SEQRES 6 A 180 LEU GLY GLN ASN LYS SER PHE TRP GLY PRO LEU GLU LEU SEQRES 7 A 180 VAL GLU LYS LEU VAL PRO GLU ALA ALA GLU ILE THR ALA SEQRES 8 A 180 SER VAL LYS ASP LEU PRO GLY LEU LYS THR PRO VAL GLY SEQRES 9 A 180 ARG GLY ARG ALA TRP LEU ARG LEU ALA LEU MET GLN LYS SEQRES 10 A 180 LYS LEU SER GLU TYR MET LYS ALA LEU ILE ASN LYS LYS SEQRES 11 A 180 GLU LEU LEU SER GLU PHE TYR GLU VAL ASN ALA LEU MET SEQRES 12 A 180 MET GLU GLU GLU GLY ALA ILE ILE ALA GLY LEU LEU VAL SEQRES 13 A 180 GLY LEU ASN VAL ILE ASP ALA ASN PHE CYS MET LYS GLY SEQRES 14 A 180 GLU ASP LEU ASP SER GLN VAL GLY VAL ILE ASP SEQRES 1 B 180 GLY SER SER GLY SER SER GLY MET ALA ASN GLU ARG MET SEQRES 2 B 180 ASN LEU MET ASN MET ALA LYS LEU SER ILE LYS GLY LEU SEQRES 3 B 180 ILE GLU SER ALA LEU ASN LEU GLY ARG THR LEU ASP SER SEQRES 4 B 180 ASP TYR ALA PRO LEU GLN GLN PHE PHE VAL VAL MET GLU SEQRES 5 B 180 HIS CYS LEU LYS HIS GLY LEU LYS ALA LYS LYS THR PHE SEQRES 6 B 180 LEU GLY GLN ASN LYS SER PHE TRP GLY PRO LEU GLU LEU SEQRES 7 B 180 VAL GLU LYS LEU VAL PRO GLU ALA ALA GLU ILE THR ALA SEQRES 8 B 180 SER VAL LYS ASP LEU PRO GLY LEU LYS THR PRO VAL GLY SEQRES 9 B 180 ARG GLY ARG ALA TRP LEU ARG LEU ALA LEU MET GLN LYS SEQRES 10 B 180 LYS LEU SER GLU TYR MET LYS ALA LEU ILE ASN LYS LYS SEQRES 11 B 180 GLU LEU LEU SER GLU PHE TYR GLU VAL ASN ALA LEU MET SEQRES 12 B 180 MET GLU GLU GLU GLY ALA ILE ILE ALA GLY LEU LEU VAL SEQRES 13 B 180 GLY LEU ASN VAL ILE ASP ALA ASN PHE CYS MET LYS GLY SEQRES 14 B 180 GLU ASP LEU ASP SER GLN VAL GLY VAL ILE ASP

FORMUL 3 HOH *31(H2 O)

HELIX 1 1 MET A 83 GLY A 109 1 27 HELIX 2 2 TYR A 116 HIS A 132 1 17 HELIX 3 3 PHE A 147 VAL A 158 1 12 HELIX 4 4 ALA A 161 LYS A 169 1 9 HELIX 5 5 THR A 176 MET A 190 1 15 HELIX 6 6 LYS A 193 ASN A 203 1 11 HELIX 7 7 LEU A 207 PHE A 211 5 5 HELIX 8 8 GLU A 221 LEU A 230 1 10 HELIX 9 9 VAL A 231 ILE A 236 5 6 HELIX 10 10 MET B 83 GLY B 109 1 27 HELIX 11 11 TYR B 116 HIS B 132 1 17 HELIX 12 12 PHE B 147 LEU B 153 1 7 HELIX 13 13 LEU B 153 VAL B 158 1 6 HELIX 14 14 ALA B 161 LYS B 169 1 9 HELIX 15 15 THR B 176 MET B 190 1 15 HELIX 16 16 LYS B 193 ASN B 203 1 11 HELIX 17 17 LYS B 204 SER B 209 1 6 HELIX 18 18 GLU B 220 LEU B 230 1 11 HELIX 19 19 VAL B 231 ILE B 236 5 6

CRYST1 57.625 77.674 88.554 90.00 90.00 90.00 P 21 21 21 8

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.017354 0.000000 0.000000 0.00000

SCALE2 0.000000 0.012874 0.000000 0.00000

SCALE3 0.000000 0.000000 0.011293 0.00000